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SUMMARY
The aim of this study was to investigate the presence of the Hepatitis G Virus on a population of blood donors from São Paulo,
Brazil and to evaluate its association to sociodemographic variables. Two RT-PCR systems targeting the putative 5’NCR and NS3
regions were employed and the former has shown a higher sensitivity.
The observed prevalence of HGV-RNA on 545 blood donors was 9.7% (CI 95% 7.4;12.5). Statistical analysis depicted an
association with race/ethnicity, black and mulatto donors being more frequently infected; and also with years of education, less
educated donors presenting higher prevalences. No association was observed with other sociodemographic parameters as age, gender,
place of birth and of residence.
DNA sequencing of nine randomly chosen isolates demonstrated the presence of genotypes 1, 2 and 3 among our population but
clustering of these Brazilian isolates was not detected upon phylogenetic analysis.
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INTRODUCTION
Hepatitis G Virus is a recently identified single-stranded RNA virus
that has been detected on blood transfusion recipients and further on
other groups presenting parenteral risk factors. It has been classified
into the Flaviviridae family sharing a similar genomic arrangement to
other members including the Hepatitis C Virus (HCV). The worldwide
prevalence of HGV on healthy populations is notably high, ranging from
2% on German blood donors15 to 14.2% on West African residents5.
Sequence analysis has allowed the classification of HGV isolates on
types and this approach revealed the existence of at least 4 genotypes.
Genotype 1 is detected mainly on African residents, genotype 2 is the
most prevalent on Europe and North America and genotypes 3 and 4 in
Asia10,11. A fifth South African genotype has also been proposed18. Though
HGV transmission by blood transfusion is firmly established1, several
lines of evidence (reviewed in KLEINMAN7) led to the conclusion that
HGV does not cause any form of liver disease, precluding the need of
screening in the blood transfusion setting. The aim of this study was to
investigate the presence of the Hepatitis G Virus on a population of blood
donors from São Paulo, Brazil and to evaluate its association to
sociodemographic variables.
METHODS
Study population: Serum samples were obtained from 545
consecutive voluntary blood donors from the Hospital Sírio-Libanês
Blood Bank (from August to November of 1997), including 380 males
and 165 females, ranging from 18 to 59 years of age. All samples were
routinely assessed for serological markers, namely; anti-HIV1/2, HBsAg,
anti-HBc, anti-HCV, anti-HTLV-I/II, ALT levels, Syphilis and Chagas
disease. Demographic data, including age, gender, marital status, race,
local of birth and residence and educational background were obtained
from donors by self-assessment.
HGV RT-PCR: RNA was extracted from 250 µL of serum by the
use of TRI Reagent LS (GIBCO BRL, São Paulo, Brazil) in accordance
with the manufacturer instructions. Total isolated RNA was submitted
to reverse transcription with Random Primers 2.5 µM (GIBCO BRL,
São Paulo, Brazil) and 50 units of Moloney Murine Leukemia Virus
Reverse Transcriptase (M-MLV RT, GIBCO BRL, São Paulo, Brazil) in
a volume of 20 µL, for 30 minutes at 37 0C followed by 5 minutes at 95 °C.
The putative HGV 5’ non-coding region was amplified from 5.0 µL of
cDNA, corresponding to 62.5 µL of serum, in a single-round PCR, using
antisense primer ( 5’ CAC TGG GTG CAA GCC CCA GAA 3’ ), sense
primer ( 5’ CAC TGG TCC TTG TCA ACT CGC 3’)9 and one unit of
Taq DNA Polymerase (GIBCO BRL, São Paulo, Brazil) in a final volume
of 25 µL. Denaturation at 95 °C for 5 minutes was followed by 40 cycles
of amplification at 94 °C for 30s, 55 °C for 30s and 72 °C for 1 minute.
On positive samples, a PCR product of 367 bp was detectable after
electrophoresis on an ethidium bromide stained, 1.8% agarose gel.
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Samples were also submitted to amplification of a distinct HGV
genomic region, the NS3 gene, presumably coding for a viral helicase/
protease, using a nested PCR protocol12. For the first round, 2.5 µL of
cDNA was submitted to PCR using antisense primer 1 (5’ CGA AGT
TTC CTG TGT ACC C 3’ ), sense primer 1 (5’ GAC GTT GGT GAG
ATC CCC TT 3’) in a final volume of 12.5 µL. For the second round
5.0 µL of first round PCR product was amplified using antisense primer
2 (5’ TAG AGA GCG CGT CTG TCG CAC 3’) and sense primer 2 (5’
TGG GCA TGG TAT CCC CCT CGA GC 3’) in a final volume of 25
µL. For both rounds, denaturation at 95 °C for 5 minutes was followed
by 40 cycles of 94 °C for 45s, 53 °C for 45s and 72 °C for 75s. 238 bp
and 196 bp were respectively first and second round PCR products
detectable after eletrophoresis on an ethidium bromide stained, 1.8%
agarose gel. Positive controls consisted of a HGV positive sample derived
from a chronic hepatitis C patient and a plasmid containing HGV cloned
sequences gently provided by Dr Jason Pickering (Imperial College,
Dept. of Medicine, London, UK). Negative controls consisted of plasma
supernatant derived from a donation negative for all serological markers
plus HCV-RNA and HGV-RNA by the methods described above.
Sequencing: PCR products from 9 randomly chosen isolates (HGV
5’ non-coding region PCR products) were purified on an ultrafiltration
system MICROCON - 100 (AMICON, INC., Beverly, USA) and
subjected to direct sequencing by using ABI PRISM Dye terminator
Cycle Sequencing Ready reaction kit (Perkin-Elmer, Foster City, USA).
Sequences were determined by using automated sequencer ABI 377 (ABI,
Foster City, USA) equipment at the DNA Sequencing Core - University
of Michigan.
Phylogenetic Analysis: Similarity of the isolates here described to
other HGV sequences was verified by a GenBank searching algorithm
(BLAST version 2.0 program), available through the National Center
for Biotechnology Information Web site (http://www.ncbi.nlm.nih.gov/
). DNA sequences representative of distinct HGV groups were obtained
from the GenBank and aligned with the sequences here reported by using
CLUSTAL-W17 software (http://dot.imgen.bcm.tmc.edu:9331/multi-
align/multi-align.html). An unrooted phylogenetic tree was constructed
based on the neighbor-joining analysis of the sequence distance data by
using the NEIGHBOR program of the PHYLIP package available through
the Web site (ftp://evolution.genetics.washington.edu/pub/phylip).
Statistical Analysis: The χ2 or χ2 for trend tests were used for
investigating the association between two categorical variables. The odds
ratio (OR) for the presence of HGV-RNA considering as exposure several
sociodemographic variables was estimated by the method of Mantel-
Haenzel6 with confidence intervals of 95%.
RESULTS
HGV-RNA was detected on 53 out of 545 serum samples (9.7%,
95% CI 7.4;12.5), by at least one of the two primers sets. Among the
HGV infected individuals, there was no reactivity to the following
serological markers: HBsAg, anti-HCV, Syphilis, Chagas disease,
HIVp24Ag and anti-HIV 1/2 (Table 1). Of the 53 reactive samples, 47
and 30 were respectively reactive to 5’ non-coding region and to NS-3
primer pairs while 24 were reactive for both (Table 2). There were no
significant associations between presence of HGV-RNA with gender (p
= 0.20) nor age (p = 0.15). The relative frequency of HGV-RNA was
higher on donors of Negro/Mulatto race (26.5%) than on Caucasians
(7.5%) and Orientals (0%) (Fig. 1) (OR = 4.5, 95% CI 2.3;8.5, Table 3).
DNA sequences comparison revealed, on all cases, more than 90% of
sequence identity to other HGV isolates previously described and
phylogenetic analysis doesn’t show a cluster of Brazilian samples (Fig.
2).
Table 1
Other serological markers on the donors study population
Marker Repeatedly reactive (%) HGV-RNA +
anti-HIV ½ 1 (0.18) -
anti-HBc 19 (3.5) 1
anti-HCV 2 (0.37) -
anti-HTLV I/II 3 (0.55) 1
HBsAg 2 (0.4) -
ALT* 8 (1.5) 1
Eletr. Hb@ 7 (1.3) 1
Chagas - -
Syphilis 2 (0.4) -
Total 545 (100) 53 (9.7%)
*ALT value > 110U/L; @ Anomalous hemoglobin electrophoresis
Table 2





Positive 24 23 47
Negative 6 492 498
Total 30 515 545
Fig. 1 - HGV-RNA prevalence by ethnic group
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DISCUSSION
We have found a very high prevalence of HGV-RNA in our blood
donor population, corroborating the data from BASSIT et al.3 on a blood
donor population from another hospital in São Paulo. A prevalence of this
magnitude has only been reported, to our knowledge, on West African
residents and South African blood donors4,5, except for parenterally exposed
groups where even higher prevalences are observed4,15. The finding of this
virus in that proportion of blood donors with no correlation to other markers
points to the little pathogenicity of this agent, if any. However, the
determinants of these high infectious rates are so far not known. It is
demonstrated the transmissibility of HGV by blood transfusion,
hemoderivates and needle sharing but these sources of risk can’t be
responsible for the 10% prevalence on the general population. Mother to
infant8 and close sexual13,14,15 contact transmission are currently thought to
contribute most to the high prevalence seen worldwide. Though we haven’t
collected data concerning sexual activity of donors, in our series there was
no association between HGV-RNA carrier state and more established
markers of risky sexual behavior like HBsAg and anti-HIV (Table 1).
However, a recently published cross-sectional study conducted with
residents in the city of São Paulo detected an association between HGV
and the number of sexual partners13. We haven’t observed an association
between HGV presence and elevation of ALT, corroborating that, to the
healthy host, HGV causes no detectable hepatic damage.
An important issue in estimating an infectious agent prevalence by
PCR is the choice of the primer system. We observed that primers
spanning the 5’NCR detected more viremic donors than the NS3 nested-
PCR, suggesting that HGV may be commonly present in a high viral
load on the donor blood (Table 2) and analogously to HCV, the 5’NCR
is conserved among isolates being the target of choice for PCR detection.
Among several sociodemographic variables studied, we observed a
positive association with black race and a trend to higher positivity on
donors reporting lower educational background. A significant association
with black race has also been observed in South African blood donors4,
although the factors for these racial differences are not known. It might
be noted that we found an odds ratio of 4.5 of black/mulatto race over
Caucasians, taking the latter as reference, but the prevalence on our
Caucasian population is very high as well (7.5%), suggesting that this
group is also exposed to the factor(s) responsible for the high prevalence
of HGV-RNA in the general population. It should be pointed that this
association remains statistically significant even after controlling for
educational level (OR = 3.2, 95%CI 1.6;6.6), what was necessary since
statistical analysis showed a trend for black/mulatto donors to have fewer
years of education (χ2 for trend p < 0.001).
It is known that viremic carriers represent only part of the exposed
individuals, after the report that an antibody against the putative viral
envelope (E2) protein correlates to virus clearance, i.e. absence of HGV-
RNA16, and was shown to be present on a prevalence 2-3 times that of
the PCR positive hosts. If this proportion proves to stand likewise to the
population here studied, we could get to a 100% exposition rate on certain
groups.
Phylogenetic analysis identified among Brazilian donors genotypes
1a, 1b, 2b and 3, according to the classification proposed by MUERHOFF
et al.10. In contrast to reports from other populations19, “Brazilian” HGV
isolates here described are not clustered, since they present higher
sequence identity to isolates from USA, Japan, Germany and West Africa
than to other Brazilian isolates, possibly reflecting the racial mixed
composition of the Brazilian population. Alternatively, this may be due
to the low number of isolates analyzed (nine). Isolate g87958 is placed
on a separate branch of the tree (Fig. 2). In depth inspection of the
alignment shows that this isolate probably represents a recombinant
between genotype 1a and 2a since it harbors 5’NCR motifs from both
genotypes. This can be due either by an amplification artifact or a genuine
in vivo recombination, as observed on a Chinese isolate2.
Table 3
Prevalence of HGV-RNA by sex, race, education and age and statistical analysis
Variable HGV-RNA + (%) Total OR 95% C.I. p-value
SEX
Female 12 (7.3) 165 0.6 0.3 ; 1.3 0.203
Male 41(10.8) 380 -
RACE
Black/Mulatto 18 (26.5) 68 4.5 2.3 ; 8.7 < 0.001
Caucasian 33 (7.5) 443 -
EDUCATION (yr)
≤ 4 18 (14.8) 122 2.3 1.1 ; 4.8 0.022 *
5-8 18 (9.6) 187 1.4 0.7 ; 2.9
≥ 9 15 (6.9) 217 -
AGE
18-25 14 (8.9) 158 1.8 0.6 ; 4.7 0.149
26-33 21 (13.5) 155 2.8 1.1 ; 7.3
34-41 12 (10.3) 116 2.1 0.7 ; 5.7
41-50 6 (9.4) 64  
–51-59 0 (0.0) 50
* p-value for a χ2 trend;  for the purpose of p-value and OR estimation, 41-50 and 51-59 groups were combined.
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RESUMO
Alta prevalência do RNA do vírus da hepatite G (HGV) em
doadores de sangue brasileiros
O objetivo deste estudo foi investigar a presença do vírus da hepatite
G e sua associação com variáveis sóciodemográficas em uma população
de doadores de sangue da cidade de São Paulo, Brasil. Dois sistemas de
PCR foram empregados, um focando a região 5’ não-codificadora e outro
a região não-estrutural 3, apresentando o primeiro maior sensibilidade.
A prevalência detectada do HGV-RNA em 545 doadores foi de 9,7%
(IC 95% 7,4;12,5). A prevalência do HGV-RNA foi significativamente
maior em doadores da raça negra/mulata (26,5%) quando comparados
aos doadores caucasianos (7,5%), (OR = 4,5). Também foi observada
uma tendência de maiores prevalências em doadores de menor
escolaridade. Não se observou associação significativa com outros
parâmetros estudados como idade, sexo, origem geográfica e local de
residência.
O sequenciamento do DNA de nove isolados selecionados ao acaso
demonstrou a presença dos genótipos 1, 2 e 3, mas não houve um
agrupamento das amostras brasileiras quando submetidas à análise
filogenética.
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